First, even though COX-2 inhibitors improve motor function and prolong the life span of G93A mice [26, 45, 46], no anti-inflammatory drugs, including COX-2 inhibitors, have shown significant benefits in clinical studies in ALS patients [94]. Here, PTGS2 is linked to amyotrophic lateral sclerosis.